Mechanism of action, resistance, interaction, pharmacokinetics, pharmacodynamics, and safety of fostemsavir

Mechanism of action, resistance, interaction, pharmacokinetics, pharmacodynamics, and safety of fostemsavir

Abstract The Food and Drug Administration (FDA) has licensed many antiretroviral medications to treat human immunodeficiency virus type 1 (HIV-1), however, treatment options for people with multi-drug resistant HIV remain limited. Medication resistance, undesirable effects, prior tolerance, and prev...

Full description

Bibliographic Details
Main Authors: Mohsen Heidary, Saeedeh Shariati, Shima Nourigheimasi, Mona Khorami, Melika Moradi, Moloudsadat Motahar, Parisa Bahrami, Sousan Akrami, Vahab Hassan Kaviar
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Infectious Diseases
Subjects:
Fostemsavir
Resistance
Human immunodeficiency virus
Antiretroviral therapy
HIV
AIDS
Online Access:https://doi.org/10.1186/s12879-024-09122-5

Internet

https://doi.org/10.1186/s12879-024-09122-5

Similar Items